404 POSTER A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors
W. Kelly, D. Petrylak, G. Blumenschein, U. Lassen, P. Buhl Jensen, J. DeBonoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72338-3
File:
PDF, 64 KB
english, 2008